Market Place
Sourcing Support
Calliditas To Present Four Abstracts At ASN Kidney Week 2024
16 Oct 2024 //
GLOBENEWSWIRE
AZ pads data package for Airsupra in patients with milder asthma
09 Oct 2024 //
FIERCE PHARMA
Enforcement Report - Week of July 10, 2024
10 Jul 2024 //
FDA
Asahi Kasei moves to buy Calliditas for more than $1B
29 May 2024 //
FIERCE PHARMA
NPPA revises ceiling price of asthma inhaler drug combination
25 May 2024 //
PHARMABIZ
Bausch Uceris® Canada Listings: For Ulcerative Colitis Treatment
23 May 2024 //
ACCESSWIRE
Smart sensor cleared for use with AZ asthma, COPD inhalers
15 Apr 2024 //
PHARMAPHORM
Calliditas to Present Nefecon Data at the ISN World Congress
08 Apr 2024 //
PR NEWSWIRE
Bausch Health Announces First Public Drug Plan Listings
03 Apr 2024 //
ACCESSWIRE
Mankind enters pact to distribute AstraZeneca`s anti-asthma drug Symbicort
11 Mar 2024 //
ECONOMIC TIMES
Calliditas announces an seven year orphan drug exclusivity period for TARPEYO®
06 Mar 2024 //
PR NEWSWIRE
Takeda wins US approval for first oral drug for eosinophilic esophagitis
13 Feb 2024 //
ENDPTS
Enforcement Report - Week of February 7, 2024
07 Feb 2024 //
FDA
AIRSUPRA available as the first & only FDA-approved anti-inflammatory option
22 Jan 2024 //
BUSINESSWIRE
Everest Medicines Announces New Drug Application Acceptance of Nefecon
26 Dec 2023 //
PR NEWSWIRE
FDA grants Calliditas full nod for kidney disease drug Tarpeyo
21 Dec 2023 //
FIERCE PHARMA
Calliditas Announces Nefecon to Significantly Slow Kidney Function Decline
20 Dec 2023 //
PR NEWSWIRE
Takeda Announces FDA Acceptance of NDA Resubmission of TAK-721
20 Sep 2023 //
BUSINESSWIRE
Stada`s Kinpeygo (budesonide) Receives Approval in Europe
21 Aug 2023 //
EMA
FDA grants priority review for full approval of TARPEYO for IgA Nephropathy
18 Aug 2023 //
PR NEWSWIRE
Viatris Announces Launch of Breyna™ Inhalation Aerosol
01 Aug 2023 //
PR NEWSWIRE
Everest Medicines Announces Completion of Patient Enrollment in Nefecon® China Open Label Extension Study
31 Jul 2023 //
PR NEWSWIRE
Stada`s Kinpeygo (budesonide) Receives Approval in Europe
17 Jul 2023 //
EMA
Calliditas Therapeutics Submits sNDA to U.S. FDA for Full Approval of TARPEYO®
21 Jun 2023 //
PR NEWSWIRE
Calliditas Reports Positive Topline Results from Phase 3 NefIgArd Trial
13 Mar 2023 //
PR NEWSWIRE
FDA approves AstraZeneca`s Airsupra rescue inhaler, but only for adults
12 Jan 2023 //
FIERCE PHARMA
AstraZeneca Nabs 6 More Months For Symbicort Patent In Latest Court Ruling
17 Dec 2022 //
ENDPTS
Stada`s Kinpeygo (budesonide) Receives Approval in the Europe
23 Nov 2022 //
EMA
Calliditas` partner Everest`s NDA for Nefecon is accepted by the NMPA
16 Nov 2022 //
PRNEWSWIRE
FDA panel delivers mixed verdict on AstraZeneca`s asthma rescue medication
10 Nov 2022 //
FIERCEBIOTECH
Kidney International Publishes Results from NefIgArd Phase 3 TrialTARPEYO
19 Oct 2022 //
PRESS RELEASE
Kidney International Publishes Results of NefIgArd PIII Trial Evaluating TARPEYO
19 Oct 2022 //
PRNEWSWIRE
FDA nixes EUA ambitions for Eiger’s COVID treatment
06 Oct 2022 //
FIERCEBIOTECH
Enforcement Report - Week of October 5, 2022
05 Oct 2022 //
FDA
Calliditas Therapeutics`s Kinpeygo (budesonide) Receives Approval in the EMA
18 Jul 2022 //
EMA
PT027, significantly Reduced the Risk of a Severe Exacerbation by 27% in Asthma
15 May 2022 //
BUSINESSWIRE
Astrazeneca`s Biologic Riltrava Aerosphere Receives Approval in Europe
04 Feb 2022 //
EMA
Calliditas Announces Commercial Availability and Initial Sales of TARPEYO
28 Jan 2022 //
PRNEWSWIRE
FDA rejects Takeda`s Eohilia, requires new trial
23 Dec 2021 //
FIERCEPHARMA
Takeda Receives Complete Response Letter from the U.S. FDA for TAK-721
21 Dec 2021 //
BUSINESSWIRE
FDA grants Accelerated Approval to Calliditas` TARPEYO in IgA Nephropathy
15 Dec 2021 //
PRNEWSWIRE
Marinomed Biotech AG and Luoxin Pharma sign agreement on Budesolv
20 Oct 2021 //
DGAP
AZ posts first-in-class win for asthma rescue inhaler
10 Sep 2021 //
FIERCEPHARMA
AZ builds case for fixed-dose albuterol and budesonide combo in asthma
09 Sep 2021 //
PHARMA TIMES
Sun Pharm`s Generic Budesonide Receives Approval In US
17 Apr 2021 //
FDA
Asthma drug Budesonide helps COVID-19 recovery at home
13 Apr 2021 //
PHARMFILE
U.S. Food and Drug Administration Accepts New Drug Application for Review,
15 Dec 2020 //
BUSINESSWIRE
European approval for AstraZeneca`s Trixeo Aerospace in moderate to severe COPD
14 Dec 2020 //
PHARMAFILE
New analyses from Breztri Aerosphere Phase III ETHOS trial to be presented
07 Sep 2020 //
PRESS RELEASE
FDA Approvals Roundup: Tecartus, Breztri Aerosphere, Wynzora
30 Jul 2020 //
RAPS
ORTIKOS™ (budesonide), the First and Only Once-Daily Dose
29 Jul 2020 //
BUSINESSWIRE
AstraZeneca’s phase III ETHOS trial of triple-combo therapy Breztri Aerosphere
25 Jun 2020 //
PHARMABIZ
Breztri Aerosphere significantly reduced rate of moderate or severe COPD
24 Jun 2020 //
PRESS RELEASE
Wasdell Group Receives IMP License for European HQ
03 Jun 2020 //
CONTRACT PHARMA
Sweden`s Calliditas seeks $75M IPO haul to bring its oral steroid
18 May 2020 //
ENDPTS
Teva Pharma`s Generic Budesonide/Formoterol Receives Approval in Europe
04 Apr 2020 //
EMA
FDA requires boxed warning for Singulair and its generics
05 Mar 2020 //
ENDPTS
FDA Requires Boxed Warning for Singulair, Generics
05 Mar 2020 //
RAPS
FARMABIOS S.P.A Fails EDQM Inspection
23 Nov 2019 //
EDQM
